The FDA has approved a new non-opioid drug for treatment of mild to moderate pain, according to a press release.
Galt Pharmaceuticals announced July 16 that Orphengesic Forte has been approved two months ahead of time via the FDA’s supplemental abbreviated new drug application program as a safer alternative for pain management. That approval was made July 8.
|